Stocktoria
Cardiff Oncology, Inc. CRDF
Cardiff Oncology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,628,407 | $5.8M | 3.85% |
| AQR CAPITAL MANAGEMENT LLC | 346,353 | $450,260 | 0.51% |
| CITADEL ADVISORS LLC | 197,400 | $256,620 | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 134,517 | $174,872 | 0.2% |
| TWO SIGMA INVESTMENTS, LP | 47,666 | $61,966 | 0.07% |
| Point72 Asset Management, L.P. | 28,385 | $36,901 | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 13,942 | $18,125 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.